Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study
about
Exploring Big Data in Hematological Malignancies: Challenges and Opportunities.A Patient with Abnormal Kidney Function and a Monoclonal Light Chain in the Urine.Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually.Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis.Attitudes about when and how to treat patients with AL amyloidosis: an international survey.Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis.Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment.Systemic amyloidosis: novel therapies and role of biomarkers.Disease burden of systemic light-chain amyloidosis: a systematic literature review.Newer Therapies for Amyloid Cardiomyopathy.Proteasome inhibitors in AL amyloidosis: focus on mechanism of action and clinical activity.Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival.Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type.Stem cell transplantation in patients with systemic AL amyloidosis referred for transplant after suboptimal responses to bortezomib-based initial therapy.Treatment patterns and health care resource utilization among patients with relapsed/refractory systemic light chain amyloidosis.New concepts in the treatment and diagnosis of amyloidosis.Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation.Predictors of early treatment failure following initial therapy for systemic immunoglobulin light-chain amyloidosis.Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation in Sweden, long-term results from all patients treated in 1994-2009.Light Chain Amyloidosis.Rationale and design of DUAL study: Doxycycline to Upgrade response in light chain (AL) amyloidosis (DUAL): A phase 2 pilot study of a two-pronged approach of prolonged doxycycline with plasma cell-directed therapy in the treatment of AL amyloidosisRevisiting conditioning dose in newly diagnosed light chain amyloidosis undergoing frontline autologous stem cell transplant: impact on response and survival.Novel Therapies in Light Chain Amyloidosis.Recent advances in understanding and treating immunoglobulin light chain amyloidosisDeferred autologous stem cell transplantation in systemic AL amyloidosis
P2860
Q31095966-FE3C8157-5BBD-43C5-9466-FF662B6E7749Q36965127-F3B42245-F2EF-4052-8324-DF984BBD76D2Q36974379-D9EFE17B-2DCE-4D15-881C-6838674B4E1EQ37570615-880D346C-4A55-4EED-BC0E-7595F23D5400Q38600436-2564654F-D132-4D25-B69B-E25F246183E0Q38652107-1F71E716-880E-43EE-882F-15CB4C1ECE4EQ38663987-E6C2AE1F-D6E1-47F3-A493-61543A304851Q38829923-625D65B4-5A39-45F2-9BCB-C2C424B2CA62Q38917828-DE97E2F7-40AA-46B1-BFC6-DBD317719D41Q38920614-C3165546-A10F-4A49-B30F-BA6702C00B7FQ38959241-BBE725FC-35A2-44C5-9180-982143098D7BQ40742235-3E06AF2E-2E0D-401C-87A7-CE2885F366A9Q41433373-6B57DD16-5A67-4494-8256-AC5460EEE489Q46048669-6B3A8560-88C3-457A-9470-94B8B703E245Q47206472-227752B7-A9F4-4979-AAF7-7BFFA63ABAF4Q47561519-EA7A94F9-518F-42C4-A2D9-0DC9D3A4093FQ47643557-C3865FDF-A692-4E03-9C5C-BAC7486D937BQ48139614-439CBF22-C4B7-49E0-8B8F-AAA9B7FA9D44Q48614453-AF40BDD3-09A0-4009-AB6A-DD4BCD69ABE7Q51786246-120D22C9-698C-4D65-9BFA-28526A450967Q52659305-34CD7E80-0F45-4668-B1A8-779FB97B384BQ52716575-D405AA18-285B-4E74-9505-30961774567BQ52777488-81C50D93-71BC-40EE-BB6A-0BD1B700C49FQ55127439-0C0F0BE0-287C-4D00-AD7C-4E87F561A863Q57166910-7AB575EA-3F7D-4CF6-A22E-76B6A6807A44Q58609453-45FA8823-5182-48D9-AF12-D9193450C4A5
P2860
Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Improved Outcomes After Autolo ...... rrow Transplant Research Study
@ast
Improved Outcomes After Autolo ...... rrow Transplant Research Study
@en
type
label
Improved Outcomes After Autolo ...... rrow Transplant Research Study
@ast
Improved Outcomes After Autolo ...... rrow Transplant Research Study
@en
prefLabel
Improved Outcomes After Autolo ...... rrow Transplant Research Study
@ast
Improved Outcomes After Autolo ...... rrow Transplant Research Study
@en
P2093
P2860
P50
P356
P1476
Improved Outcomes After Autolo ...... rrow Transplant Research Study
@en
P2093
Anita D'Souza
Baldeep Wirk
Bipin N Savani
Brendan M Weiss
César O Freytes
Dan T Vogl
Emma C Scott
Heather J Landau
Jan S Moreb
Jiaxing Huang
P2860
P304
P356
10.1200/JCO.2015.62.4015
P407
P577
2015-09-14T00:00:00Z